Presentation Information

[5AAM-01]Evaluation of treatment differences after the double-blind period of clinical trial for myasthenia gravis using external data

〇五十川 直樹1、Berggren Lovisa2 (1. ユーシービージャパン株式会社、2. UCB S.A.)